「in vitroinvivoin vitroinvivo」の検索結果
158件:76~80件目を表示
-
オロパタジン点眼液0.1%「センジュ」
感作モルモットの抗原誘発によ る眼瞼と眼球結膜の充血及び膨疹を抑制 (ED50値:0.017%) し た12) 。 19. 有効成分に関する理化学的知見 一般名:オロパタジン塩酸塩 (Olopatadine Hydrochloride) 〔JAN〕 化学名: {11-[ (1 ) -3- (Dimethylamino) propylidene]-6, 11- dihydrodibenzo[b, e...
https://www.senju.co.jp/sites/default/files/product_other_file/2023-10/olopatadine_202312_C3.pdf -
お知らせ | 千寿製薬株式会社
March 7, 2025 Announcement of Licensing Agreement with Brill International(PDF) February 20, 2025 Launch and Distribution of “MIEr for BeelineMED”(PDF) January 17, 2025 Senju has Applied for Manufactu...
https://www.senju.co.jp/english/news/ -
产品介绍 | 海外活动 | 千寿制药株式会社
亚洲 中东 欧洲 北美和南美 亚洲 印度 产品 Marketing Authorisation Holder JP Brand Name GLUCOTIM-LA Centaur Pharmaceuticals PVT LTD Not marketed in JP 韩国 产品 Marketing Authorisation Holder JP Brand Name BRONUCK Taejoon P...
http://www.senju.co.jp/chinese/global/world.html -
Production | About Senju | SENJU Pharmaceutical
Trusted pharmaceutical products are created using the latest and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as inject...
https://www.senju.co.jp/english/about/production.html -
Presence of Products | Overseas Activities | SENJU Pharmaceutical
Asia Middle East Europe North&South Ameica Asia India Brand Name Marketing Authorisation Holder JP Brand Name GLUCOTIM-LA Centaur Pharmaceuticals PVT LTD Not marketed in JP Korea Brand Name Market...
https://www.senju.co.jp/english/global/world.html